These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19265140)

  • 1. Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptors.
    Hammond JA; Guethlein LA; Abi-Rached L; Moesta AK; Parham P
    J Immunol; 2009 Mar; 182(6):3618-27. PubMed ID: 19265140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation at positively selected positions in the binding site for HLA-C shows that KIR2DL1 is a more refined but less adaptable NK cell receptor than KIR2DL3.
    Hilton HG; Vago L; Older Aguilar AM; Moesta AK; Graef T; Abi-Rached L; Norman PJ; Guethlein LA; Fleischhauer K; Parham P
    J Immunol; 2012 Aug; 189(3):1418-30. PubMed ID: 22772445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of demethylation treatment on the expression of inhibitory receptor KIR gene in NK-92MI cell line].
    Gao XN; Lin J; Wang LL; Gao L; Jin HJ; Sun JF; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):656-60. PubMed ID: 19549382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell receptors in the horse: evidence for the existence of multiple transcribed LY49 genes.
    Takahashi T; Yawata M; Raudsepp T; Lear TL; Chowdhary BP; Antczak DF; Kasahara M
    Eur J Immunol; 2004 Mar; 34(3):773-784. PubMed ID: 14991607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphic HLA-C Receptors Balance the Functional Characteristics of KIR Haplotypes.
    Hilton HG; Guethlein LA; Goyos A; Nemat-Gorgani N; Bushnell DA; Norman PJ; Parham P
    J Immunol; 2015 Oct; 195(7):3160-70. PubMed ID: 26311903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of natural killer cell receptors: coexistence of functional Ly49 and KIR genes in baboons.
    Mager DL; McQueen KL; Wee V; Freeman JD
    Curr Biol; 2001 Apr; 11(8):626-30. PubMed ID: 11369209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
    Moesta AK; Norman PJ; Yawata M; Yawata N; Gleimer M; Parham P
    J Immunol; 2008 Mar; 180(6):3969-79. PubMed ID: 18322206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues.
    Abi-Rached L; Parham P
    J Exp Med; 2005 Apr; 201(8):1319-32. PubMed ID: 15837816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantity of HLA-C surface expression and licensing of KIR2DL+ natural killer cells.
    Charoudeh HN; Schmied L; Gonzalez A; Terszowski G; Czaja K; Schmitter K; Infanti L; Buser A; Stern M
    Immunogenetics; 2012 Oct; 64(10):739-45. PubMed ID: 22772778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of NK receptors: a single Ly49 and multiple KIR genes in the cow.
    McQueen KL; Wilhelm BT; Harden KD; Mager DL
    Eur J Immunol; 2002 Mar; 32(3):810-7. PubMed ID: 11870625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer cell receptor genes in the family Equidae: not only Ly49.
    Futas J; Horin P
    PLoS One; 2013; 8(5):e64736. PubMed ID: 23724088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resurrecting KIR2DP1: A Key Intermediate in the Evolution of Human Inhibitory NK Cell Receptors That Recognize HLA-C.
    Hilton HG; Blokhuis JH; Guethlein LA; Norman PJ; Parham P
    J Immunol; 2017 Mar; 198(5):1961-1973. PubMed ID: 28122963
    [No Abstract]   [Full Text] [Related]  

  • 13. Ly49 receptors: evolution, genetic diversity, and impact on immunity.
    Rahim MM; Makrigiannis AP
    Immunol Rev; 2015 Sep; 267(1):137-47. PubMed ID: 26284475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.
    Romagné F; André P; Spee P; Zahn S; Anfossi N; Gauthier L; Capanni M; Ruggeri L; Benson DM; Blaser BW; Della Chiesa M; Moretta A; Vivier E; Caligiuri MA; Velardi A; Wagtmann N
    Blood; 2009 Sep; 114(13):2667-77. PubMed ID: 19553639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
    Schönberg K; Sribar M; Enczmann J; Fischer JC; Uhrberg M
    Blood; 2011 Jan; 117(1):98-107. PubMed ID: 20935255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide selectivity discriminates NK cells from KIR2DL2- and KIR2DL3-positive individuals.
    Cassidy S; Mukherjee S; Myint TM; Mbiribindi B; North H; Traherne J; Mulder A; Claas FH; Purbhoo MA; Das J; Khakoo SI
    Eur J Immunol; 2015 Feb; 45(2):492-500. PubMed ID: 25359276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation.
    David G; Djaoud Z; Willem C; Legrand N; Rettman P; Gagne K; Cesbron A; Retière C
    J Immunol; 2013 Nov; 191(9):4778-88. PubMed ID: 24078689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough!
    Pascal V; Stulberg MJ; Anderson SK
    Immunol Rev; 2006 Dec; 214():9-21. PubMed ID: 17100872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA reduces killer cell Ig-like receptor expression level and frequency in a humanized mouse model.
    van Bergen J; Thompson A; van Pel M; Retière C; Salvatori D; Raulet DH; Trowsdale J; Koning F
    J Immunol; 2013 Mar; 190(6):2880-5. PubMed ID: 23390293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIR Polymorphism Modulates the Size of the Adaptive NK Cell Pool in Human Cytomegalovirus-Infected Individuals.
    Manser AR; Scherenschlich N; Thöns C; Hengel H; Timm J; Uhrberg M
    J Immunol; 2019 Oct; 203(8):2301-2309. PubMed ID: 31519864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.